新里程：公司股票交易异常波动，公司不存在违反信息公平披露的情形

Core Viewpoint - The stock price of Xinlicheng has experienced an abnormal fluctuation, with a cumulative increase of over 20% in the closing price over two consecutive trading days, prompting a self-examination by the company which found no violations of information disclosure regulations [1] Company Summary - Xinlicheng is primarily engaged in the production and sales of pharmaceuticals and hospital management [1] - For the period from January to September 2025, Xinlicheng reported a revenue of 2.256 billion yuan, representing a year-on-year decline of 23.40% (adjusted) [1] - The company incurred a net loss of 38 million yuan, with the loss expanding by 167.83% year-on-year (adjusted) [1] Industry Summary - On January 13, the Ministry of Civil Affairs and seven other departments issued measures to cultivate the operating entities in the elderly care service sector and promote the development of the silver economy, proposing 14 specific measures across five areas [1]